X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercebiotech.com/biotech/relay-loses-interest-shp2-inhibitor-after-genentech-abandons-collab
https://www.globenewswire.com/news-release/2024/08/06/2925453/0/en/Relay-Therapeutics-Reports-Second-Quarter-2024-Financial-Results-and-Corporate-Highlights.html
https://www.globenewswire.com/news-release/2024/07/30/2921387/0/en/Relay-Therapeutics-to-Announce-Second-Quarter-2024-Financial-Results-and-Corporate-Highlights-on-August-6-2024.html
https://www.fiercebiotech.com/biotech/genentech-sinks-shp2-pact-leaving-relay-race-thinning-field
https://www.globenewswire.com/news-release/2024/06/06/2894546/0/en/Relay-Therapeutics-Discloses-Three-New-Programs-at-New-Program-Platform-Event.html
https://www.globenewswire.com/news-release/2024/06/05/2894267/0/en/Relay-Therapeutics-Announces-Clinical-Trial-Collaboration-with-Pfizer-to-Evaluate-Atirmociclib-in-Combination-with-RLY-2608.html
https://www.globenewswire.com/news-release/2024/05/21/2886031/0/en/Relay-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html
https://www.globenewswire.com/news-release/2024/05/13/2880444/0/en/Relay-Therapeutics-to-Host-New-Program-and-Platform-Event-on-June-6-2024.html
https://www.globenewswire.com/news-release/2024/05/02/2874722/0/en/Relay-Therapeutics-Reports-First-Quarter-2024-Financial-Results-and-Corporate-Highlights.html
https://www.globenewswire.com/news-release/2024/04/25/2870066/0/en/Relay-Therapeutics-to-Announce-First-Quarter-2024-Financial-Results-and-Corporate-Highlights-on-May-2-2024.html
Market Place
Share 
